Results 351 to 360 of about 2,028,209 (394)
RETRACTION: Profiling of Circulating Tumor Cells for Screening of Selective Inhibitors of Tumor-Initiating Stem-Like Cells. [PDF]
Adv Sci (Weinh)europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Materials and Methods, 2017
In most solid tumors, it is distant metastases rather than the primary tumor which limit the prognosis. Distant metastases are caused by circulating tumor cells (CTCs) which actively invade the blood stream, attach to the endothelium in the target organ, invade the surrounding parenchyma, and form new tumors.
Sebastian Schölch +4 more
openaire +5 more sources
In most solid tumors, it is distant metastases rather than the primary tumor which limit the prognosis. Distant metastases are caused by circulating tumor cells (CTCs) which actively invade the blood stream, attach to the endothelium in the target organ, invade the surrounding parenchyma, and form new tumors.
Sebastian Schölch +4 more
openaire +5 more sources
Circulating Tumor Cells and Circulating Tumor DNA
Annual Review of Medicine, 2012Solid tumors derived from epithelial tissues (carcinomas) are responsible for 90% of all new cancers in Europe, and the main four tumor entities are breast, prostate, lung, and colon cancer. Present tumor staging is mainly based on local tumor extension, metastatic lymph node involvement, and evidence of overt distant metastasis obtained by imaging ...
Heidi Schwarzenbach +2 more
openaire +3 more sources
2014 World Automation Congress (WAC), 2014 Circulating tumor cells (CTCs) are tumor cells that shed from primary tumor and circulate in peripheral blood, and can be a useful clinical marker in early diagnosis and monitoring therapeutic effects for patients with malignant tumors. Detection of rare CTCs contaminated among a large number of hematologic cells presents a technical challenge, but ...
Kazue Yoneda, Fumihiro Tanaka
openaire +1 more source
2010
Circulating tumor cells (CTCs) can be separated and characterized from normal hematopoietic cellular constituents by a variety of methods. Different strategies have included separation by physical characteristics, such as size or weight, or by biological characteristics, such as expression of epithelial or cancer-specific markers.
Daniel F. Hayes, Jeffrey B. Smerage
openaire +3 more sources
Circulating tumor cells (CTCs) can be separated and characterized from normal hematopoietic cellular constituents by a variety of methods. Different strategies have included separation by physical characteristics, such as size or weight, or by biological characteristics, such as expression of epithelial or cancer-specific markers.
Daniel F. Hayes, Jeffrey B. Smerage
openaire +3 more sources
Tumor heterogeneity and circulating tumor cells
Cancer Letters, 2016In patients with cancer, individualized treatment strategies are generally guided by an analysis of molecular biomarkers. However, genetic instability allows tumor cells to lose monoclonality and acquire genetic heterogeneity, an important characteristic of tumors, during disease progression.
Chufeng Zhang +4 more
openaire +3 more sources